Subhash Banerjee

ORCID: 0000-0003-0863-7914
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Peripheral Artery Disease Management
  • Vascular Procedures and Complications
  • Cardiac Imaging and Diagnostics
  • Cerebrovascular and Carotid Artery Diseases
  • Acute Myocardial Infarction Research
  • Cardiac, Anesthesia and Surgical Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Valve Diseases and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Aortic aneurysm repair treatments
  • Cardiac and Coronary Surgery Techniques
  • Central Venous Catheters and Hemodialysis
  • Atrial Fibrillation Management and Outcomes
  • Radiation Dose and Imaging
  • Cardiac pacing and defibrillation studies
  • Infective Endocarditis Diagnosis and Management
  • Lipoproteins and Cardiovascular Health
  • Acute Ischemic Stroke Management
  • Cardiac Arrhythmias and Treatments
  • Diagnosis and Treatment of Venous Diseases
  • Pain Management and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Coronary Artery Anomalies
  • Renal and Vascular Pathologies

Baylor University Medical Center
2014-2025

Baylor Scott & White Health
2023-2025

VA North Texas Health Care System
2015-2024

The University of Texas Southwestern Medical Center
2015-2024

Baylor Jack and Jane Hamilton Heart and Vascular Hospital
2016-2024

Baylor Medical Center at Garland
2023-2024

Baylor University
2023-2024

Guru Ghasidas Vishwavidyalaya
2021-2023

Laboratoire Lorrain de Recherche en Informatique et ses Applications
2023

Dallas VA Medical Center
2006-2023

AimsDue to a high burden of systemic cardiovascular events, current guidelines recommend the use statins in all patients with peripheral artery disease (PAD). We sought study impact statin on limb prognosis symptomatic PAD enrolled international REACH registry.

10.1093/eurheartj/ehu080 article EN European Heart Journal 2014-02-28

10.1016/s0002-9149(18)31266-9 article EN The American Journal of Cardiology 2018-08-01
Menno V. Huisman Kenneth J. Rothman Miney Paquette Christine Teutsch Hans‐Christoph Diener and 95 more Sérgio Dubner Jonathan L. Halperin Chang Sheng Kristina Zint Amelie Elsaesser Dorothee B. Bartels Gregory Y.H. Lip Dzifa Wosornu Abban Nasser Abdul Mark Abelson Alan Ackermann Fran Adams Luthando Adams Pedro Adragão Walter Ageno Rajesh Aggarwal Sergio Agosti Javier A. Marin Francisco Aguilar Julio Alberto Aguilar Linares Luis Aguinaga Zia Ahmad Paul Ainsworth Kamal Al Ghalayini Saad Al Ismail Abdelfatah Alasfar Abdul Alawwa Raed Al-Dallow Lisa Alderson Dimitrios Alexopoulos Abdullah Ali Malik Ali Pareed Aliyar Tammam Al-Joundi Soufian Al Mahameed Hossein Almassi Khalid Almuti Mohamed Al-Obaidi Mohamed Al‐Shehri Ute Altmann Alvaro Rabelo Alves Ayham Al-Zoebi W. Amara Mathieu Amelot Nima Amjadi Fabrizio Ammirati Nabil Andrawis Denis Angoulvant Giorgio Annoni Gerardo Ansalone Sorin Alexandru Antonescu M. Kevin Ariani Juan Carlos Arias Sébastien Armero Rohit Arora Chander Arora William Ashcraft Muhammad Shakil Aslam Alfredo Astesiano Philippe Audouin Charles Augenbraun Şenay Aydın Rabih R. Azar Abul Azim Shahid Aziz Luciano Marcelo Backes Mirza Amir Baig Suchdeep Bains Asaad I. Bakbak Seth Baker Karim Bakhtiar Richard Bala Jonathan Banayan Stellan Bandh Shigenobu Bando Subhash Banerjee Alan J. Bank О. Л. Барбараш Gonzalo Barón‐Esquivias Craig Barr Carlos M. Barrera John R. Barton Vanja Bašić Kes Giovanni Baula Hamid el Bayeh Nooshin Bazargani Steffen Behrens Alan Bell Juan Benezet‐Mazuecos Bouziane Benhalima Philippe Berdagué Brian J. Berg van den P.F.M.M. Bergen van Edvard Berngard Richard A. Bernstein

GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns patients newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non–vitamin K antagonist oral anticoagulant (NOAC), became available. This study sought to describe phase baseline data and compare these pre-NOAC era collected during 1. During 2,...

10.1016/j.jacc.2016.11.061 article EN cc-by-nc-nd Journal of the American College of Cardiology 2017-02-01

We sought to determine the contemporary prevalence and management of coronary chronic total occlusions (CTO) in a veteran population.The CTOs various populations has received limited study.We collected clinical angiographic data consecutive patients that underwent angiography at our institution between January 2011 December 2012. Coronary artery disease (CAD) was defined as ≥50% diameter stenosis ≥1 artery. CTO occlusion ≥3 month duration.Among 1,699 who during study period, 20% did not have...

10.1002/ccd.25264 article EN Catheterization and Cardiovascular Interventions 2013-10-19

This study examined a large registry to determine the frequency, predictors, and outcomes of native coronary artery versus bypass graft percutaneous intervention (PCI) in patients with prior surgery (CABG). The PCI target vessel corresponding CABG are poorly studied. We analyzed frequency factors associated undergoing between January 1, 2004, June 30, 2009, National Cardiovascular Data Registry (NCDR) CathPCI Registry. Generalized estimating equations logistic regression modeling was used...

10.1016/j.jcin.2011.03.018 article EN publisher-specific-oa КАРДИОЛОГИЯ УЗБЕКИСТАНА 2011-08-01

AimsTo test the hypothesis that near-infrared spectroscopy (NIRS) combined with intravascular ultrasound (IVUS) would provide novel information of human coronary plaque characterization.

10.1093/eurheartj/ehr387 article EN cc-by European Heart Journal 2011-10-20

Background: In the ISCHEMIA trial (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches), an initial invasive strategy did not significantly reduce rates cardiovascular events or all-cause mortality in comparison a conservative patients stable ischemic heart disease moderate/severe myocardial ischemia. The most frequent component composite end points was infarction (MI). Methods: prespecified that primary major secondary be analyzed using 2 MI...

10.1161/circulationaha.120.047987 article EN Circulation 2020-12-03

Background High success rates are achievable for chronic total occlusion ( CTO ) percutaneous coronary intervention PCI using the hybrid approach, but periprocedural complications remain of concern. Although scores estimating and efficiency in have been developed, there is currently no available score estimation risk complications. We sought to develop a scoring tool prediction during . Methods Results analyzed data from 1569 s Prospective Global Registry Study Chronic Total Occlusion...

10.1161/jaha.116.004272 article EN cc-by-nc-nd Journal of the American Heart Association 2016-10-03

Objectives To examine the success and complication rates in percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) caused by in‐stent restenosis (ISR). Background PCI occlusive disease has traditionally been associated with low rates. We sought to angiographic procedural outcomes of patients who underwent CTO due ISR using novel “hybrid” algorithm, compare them de novo CTOs. Methods examined 521 consecutive at five high‐volume centers United States approach. Clinical,...

10.1002/ccd.25465 article EN Catheterization and Cardiovascular Interventions 2014-02-28
James Slater David J. Maron Philip G. Jones Sripal Bangalore Harmony R. Reynolds and 95 more Zhuxuan Fu Gregg W. Stone Ruth Kirby Judith S. Hochman John A. Spertus Kreton Mavromatis Jason Linefsky Todd Q. Miller Subhash Banerjee Jonathan Newman Robert Donnino Muhamed Sarić Khaled Abdul-Nour Peter Stone James J. Jang Gennie Yee Steven Weitz Suzanne V. Arnold James H. O’Keefe Michael D. Shapiro Steven Fein Mikhail Torosoff Radmila Lyubarova Sulagna Mookherjee Krzysztof Drzymalski Edward O. McFalls Santiago García Stefan Bertog Rizwan A. Siddiqui Areef Ishani Ronnell A. Hansen Michel G. Khouri Jonathan Goldberg Richard S. Goldweit Ronny Cohen Brooks Mirrer Victor J. Navarro David E. Winchester Marvin W. Kronenberg Christopher McFarren John F. Heitner Ira Dauber Charles R. Cannan Sriram Sudarshan Puja K. Mehta Michael McDaniel Stamatios Lerakis Arshed A. Quyyumi Nanette K. Wenger Chester M. Hedgepeth Heather Hurlburt Alan Rosen Zakir Sahul Steve Leung Hassan Reda Khaled M. Ziada Sampoornima Setty Rajat S. Barua Fadi G. Hage James E. Davies Massoud A. Leesar Jaekyeong Heo Amy Iskandrian Firas Al Solaiman Satinder P. Singh Khaled Dajani Mohammad El‐Hajjar Paul Der Mesropian Joseph Sacco Brian McCandless Marisa Orgera Mandeep S. Sidhu Imran Arif Hanan Kerr Jorge F. Trejo Gerald F. Fletcher Gary E. Lane Lynn M. Neeson Pragnesh Parikh Peter Pollak Brian P. Shapiro Kevin Landolfo Anthony Gemignani Daniel J. O’Rourke Judith Meadows Jason T. Call Joseph Hannan Robert M. Bojar Deepti Kumar John Mukai Edward T. Martin Gabriel Vorobiof Alec J. Moorman Scott Kinlay Robert J. Hamburger

BACKGROUND: The appropriate use criteria for revascularization of stable ischemic heart disease have not been evaluated using randomized data. Using data from the ISCHEMIA trial (International Study Comparative Health Effectiveness with Medical and Invasive Approaches; July 2012 to January 2018, 37 countries), health status benefits an invasive strategy over a conservative one were examined within scenarios. METHODS: Among 1833 participants mapped 36 scenarios, symptom was assessed Seattle...

10.1161/circoutcomes.124.010849 article EN Circulation Cardiovascular Quality and Outcomes 2025-02-26
Coming Soon ...